Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Spectral Medical Inc EDTXF


Primary Symbol: T.EDT

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical Provides Tigris Trial Update

GlobeNewswire 8 days ago

Spectral Medical Chair to Retire From the Board of Directors

GlobeNewswire April 2, 2024

Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update

GlobeNewswire March 28, 2024

Spectral Medical Provides February Tigris Trial Update

GlobeNewswire February 28, 2024

Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation

GlobeNewswire February 21, 2024

Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients

GlobeNewswire February 15, 2024

Spectral Medical Provides Early February Tigris Trial Update

GlobeNewswire February 5, 2024

Spectral Medical Provides January Tigris Trial Update

GlobeNewswire January 30, 2024

Spectral Medical Enrolls Patient 82 in Its Phase 3 FDA Tigris Septic Shock Trial

GlobeNewswire January 10, 2024

Spectral Medical Provides Tigris Trial Update

GlobeNewswire December 14, 2023

Spectral Medical Provides November Tigris Trial Update

GlobeNewswire December 4, 2023

Spectral Medical Announces CFO Departure

GlobeNewswire December 1, 2023

Sidoti Events, LLC's Virtual November Micro-Cap Conference

Accesswire November 14, 2023

Spectral Medical Announces Publication of Tigris Trial Methods Paper and Simulation of Results

GlobeNewswire November 14, 2023

Spectral Medical Announces Third Quarter Results and Provides Corporate Update

GlobeNewswire November 9, 2023

Spectral Medical Provides Tigris Trial Update

GlobeNewswire November 7, 2023

Spectral opens Tigris clinical trial site at the Mayo Clinic

Jonathon Brown October 16, 2023

Spectral Medical Announces Opening of Tigris Clinical Trial Site at the Mayo Clinic

GlobeNewswire October 16, 2023

Spectral Medical Provides Tigris Trial Update

GlobeNewswire October 3, 2023

Spectral Medical Provides Board Update

GlobeNewswire October 2, 2023